Paper41998294
Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics.
Liu Y and 3 others. Apoptosis, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics. Papers, record 41998294. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41998294
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Apoptosis | Major topic |
| Humans | |
| Pyroptosis | |
| Ferroptosis | |
| Immunotherapy | |
| Necroptosis | |
| Animals | |
| Tumor Microenvironment |
Source PubMed
References323
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38269375 | Gender differences, environmental pressures, tumor characteristics, and death rate in a lung cancer cohort: a seven-years Bayesian survival analysis using cancer registry data from a contaminated area in Italy. | Front Public Health | 2023 | https://conductscience.org/library/papers/38269375 | PubMed |
| 2 | 37479810 | The global burden of lung cancer: current status and future trends. | Nat Rev Clin Oncol | 2023 | https://conductscience.org/library/papers/37479810 | PubMed |
| 3 | 38357203 | Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy. | Front Oncol | 2024 | https://conductscience.org/library/papers/38357203 | PubMed |
| 4 | 31454018 | Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. | JAMA | 2019 | https://conductscience.org/library/papers/31454018 | PubMed |
| 5 | 31691957 | Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC). | Cancer | 2020 | https://conductscience.org/library/papers/31691957 | PubMed |
| 6 | 35288298 | Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC. | Semin Cancer Biol | 2022 | https://conductscience.org/library/papers/35288298 | PubMed |
| 7 | 34742351 | The role of ferroptosis in lung cancer. | Biomark Res | 2021 | https://conductscience.org/library/papers/34742351 | PubMed |
| 8 | 29362479 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. | Cell Death Differ | 2018 | https://conductscience.org/library/papers/29362479 | PubMed |
| 9 | 25236395 | Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. | Cell Death Differ | 2015 | https://conductscience.org/library/papers/25236395 | PubMed |
| 10 | 35963853 | Regulated cell death (RCD) in cancer: key pathways and targeted therapies. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35963853 | PubMed |
| 11 | 37550363 | The therapeutic potential of targeting regulated non-apoptotic cell death. | Nat Rev Drug Discov | 2023 | https://conductscience.org/library/papers/37550363 | PubMed |
| 12 | 36612290 | The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612290 | PubMed |
| 13 | 38753784 | DNA damage induces p53-independent apoptosis through ribosome stalling. | Science | 2024 | https://conductscience.org/library/papers/38753784 | PubMed |
| 14 | 35650427 | Drugging the efferocytosis process: concepts and opportunities. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/35650427 | PubMed |
| 15 | 32873928 | Emerging connectivity of programmed cell death pathways and its physiological implications. | Nat Rev Mol Cell Biol | 2020 | https://conductscience.org/library/papers/32873928 | PubMed |
| 16 | 31100266 | The Coming Decade of Cell Death Research: Five Riddles. | Cell | 2019 | https://conductscience.org/library/papers/31100266 | PubMed |
| 17 | 35432318 | Programmed Cell Death Tunes Tumor Immunity. | Front Immunol | 2022 | https://conductscience.org/library/papers/35432318 | PubMed |
| 18 | 33785842 | Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/33785842 | PubMed |
| 19 | 32778143 | Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. | J Hematol Oncol | 2020 | https://conductscience.org/library/papers/32778143 | PubMed |
| 20 | 28764929 | Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28764929 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42504199 | Machine learning prioritization identifies PANX1 as an inflammation-associated candidate regulator in lung adenocarcinoma. | Front Genet | 2026 | https://conductscience.org/library/papers/42504199 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41998294
GET https://conductscience.org/api/papers/v1/41998294/references?page=2